77 related articles for article (PubMed ID: 15108249)
21. Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantation.
Weston SJ; Leistikow RL; Reddy KR; Torres M; Wertheimer AM; Lewinsohn DM; Chou S; Davey MP; Corless C; O'Farrelly C; Nelson DR; Rosen HR
Hepatology; 2005 Jan; 41(1):72-81. PubMed ID: 15619226
[TBL] [Abstract][Full Text] [Related]
22. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
Chu CM; Sheen IS; Liaw YF
Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
[TBL] [Abstract][Full Text] [Related]
23. Intra portal donor specific antigen transfusion might prevent re-infection of hepatitis C virus after living related liver transplantation in hepatitis C hepatic cirrhosis.
Sato Y; Oya H; Yamamoto S; Kobayashi T; Watanabe T; Kokai H; Yamagiwa S; Hatakeyama K
Hepatogastroenterology; 2009; 56(89):205-7. PubMed ID: 19453058
[TBL] [Abstract][Full Text] [Related]
24. Impact of anti-hepatitis C virus (HCV) antibody on outcomes in renal transplant recipients infected with HCV.
Minz M; Sharma A; Das A; Chawla Y
Transplant Proc; 2008 Sep; 40(7):2386-8. PubMed ID: 18790242
[TBL] [Abstract][Full Text] [Related]
25. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
[TBL] [Abstract][Full Text] [Related]
26. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort.
Post JJ; Pan Y; Freeman AJ; Harvey CE; White PA; Palladinetti P; Haber PS; Marinos G; Levy MH; Kaldor JM; Dolan KA; Ffrench RA; Lloyd AR; Rawlinson WD;
J Infect Dis; 2004 May; 189(10):1846-55. PubMed ID: 15122521
[TBL] [Abstract][Full Text] [Related]
27. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
28. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C.
Xu DZ; Xie Y; Li ZQ
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):550-3. PubMed ID: 16286260
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection.
Kugelmas M; Osgood MJ; Trotter JF; Bak T; Wachs M; Forman L; Kam I; Everson GT
Liver Transpl; 2003 Nov; 9(11):1159-65. PubMed ID: 14586876
[TBL] [Abstract][Full Text] [Related]
30. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
[TBL] [Abstract][Full Text] [Related]
31. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus kinetics during and immediately after liver transplantation.
Garcia-Retortillo M; Forns X; Feliu A; Moitinho E; Costa J; Navasa M; Rimola A; Rodes J
Hepatology; 2002 Mar; 35(3):680-7. PubMed ID: 11870384
[TBL] [Abstract][Full Text] [Related]
33. Cellular immune response and cytokine profile among hepatitis C positive living donor renal transplant recipients.
Justa S; Minz RW; Minz M; Sharma A; Pasricha N; Anand S; Chawla YK; Sakhuja VK
Transplantation; 2010 Sep; 90(6):654-60. PubMed ID: 20622752
[TBL] [Abstract][Full Text] [Related]
34. High levels of hepatitis C virus RNA in native livers correlate with the development of cholestatic hepatitis in liver allografts and a poor outcome.
Deshpande V; Burd E; Aardema KL; Ma CK; Moonka DK; Brown KA; Abouljoud MS; Nakhleh RE
Liver Transpl; 2001 Feb; 7(2):118-24. PubMed ID: 11172395
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus-specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells.
Roque-Cuéllar MC; Sánchez B; García-Lozano JR; Praena-Fernández JM; Márquez-Galán JL; Núñez-Roldán A; Aguilar-Reina J
Liver Int; 2014 Jul; 34(6):e80-8. PubMed ID: 24127783
[TBL] [Abstract][Full Text] [Related]
36. Virological response for recurrent hepatitis C improves long-term survival in liver transplant recipients.
Tanaka T; Selzner N; Therapondos G; Renner EL; Lilly LB
Transpl Int; 2013 Jan; 26(1):42-9. PubMed ID: 23137287
[TBL] [Abstract][Full Text] [Related]
37. Frequency of regulatory T-cell and hepatitis C viral antigen-specific immune response in recurrent hepatitis C after liver transplantation.
Utsumi M; Takaki A; Umeda Y; Koike K; Napier SC; Watanabe N; Sadamori H; Shinoura S; Yoshida R; Nobuoka D; Yasunaka T; Nakayama E; Yamamoto K; Fujiwara T; Yagi T
Transpl Immunol; 2014 Jun; 31(1):33-41. PubMed ID: 24907425
[TBL] [Abstract][Full Text] [Related]
38. Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection.
Gramenzi A; Andreone P; Loggi E; Foschi FG; Cursaro C; Margotti M; Biselli M; Bernardi M
J Viral Hepat; 2005 Sep; 12(5):525-30. PubMed ID: 16108769
[TBL] [Abstract][Full Text] [Related]
39. Association between HLA class II antigens and hepatitis C virus infection.
Scotto G; Fazio V; D'Alessandro G; Monno L; Saracino A; Palumbo E; Angarano G
J Biol Regul Homeost Agents; 2003; 17(4):316-21. PubMed ID: 15065760
[TBL] [Abstract][Full Text] [Related]
40. [The systemic and local immune responses in patients with alcoholic liver cirrhosis depending on hepatitis C viral infection (HCV)].
Kolarski V; Petrova D; Naumova E; Mikhaĭlova A; Teokharov P; Dzhonova D; Todorov A; Slavchev B; Diankova L
Vutr Boles; 1999; 31(1):23-7. PubMed ID: 10847145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
